Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8N2 |
| Molecular Weight | 120.1518 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)C1=CC=CC=C1
InChI
InChIKey=PXXJHWLDUBFPOL-UHFFFAOYSA-N
InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)
| Molecular Formula | C7H8N2 |
| Molecular Weight | 120.1518 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization. | 2004-04-02 |
|
| Collagen degradation by host-derived enzymes during aging. | 2004-03 |
|
| Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists. | 2004-02-15 |
|
| Understanding protein-ligand interactions: the price of protein flexibility. | 2004-01-30 |
|
| Protein interaction networks by proteome peptide scanning. | 2004-01 |
|
| Cloning and characterization of a transmembrane-type serine protease from rat kidney, a new sodium channel activator. | 2003-12-13 |
|
| Characterization of a trypsin-like serine protease of activated B cells mediating the cleavage of surface proteins. | 2003-12-05 |
|
| Synthesis of L-ascorbic acid in the phloem. | 2003-11-24 |
|
| [Preparation of high-purity and safe autologous plasmin and its clinical application]. | 2003-11 |
|
| Multinuclear magnetic resonance and theoretical calculations in the study of structure and tautomerism of some 2-amino-N'-(aryl)-benzamidines. | 2003-11 |
|
| Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions. | 2003-10-18 |
|
| Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants. | 2003-10-09 |
|
| CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. | 2003-10-06 |
|
| Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. | 2003-09-01 |
|
| Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors. | 2003-09 |
|
| Molecular cloning of trypsin-like cDNAs and comparison of proteinase activities in the salivary glands and gut of the tarnished plant bug Lygus lineolaris (Heteroptera: Miridae). | 2003-09 |
|
| [Purification and characterization of the fibrinolytic enzyme from Agkistrodon halys halys venom]. | 2003-08-15 |
|
| Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide. | 2003-08-14 |
|
| Novel oxidative alpha-tosyloxylation of alcohols with iodosylbenzene and p-toluenesulfonic acid and its synthetic use for direct preparation of heteroaromatics. | 2003-08-08 |
|
| Engineering the primary substrate specificity of Streptomyces griseus trypsin. | 2003-08-05 |
|
| Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketones. | 2003-08-05 |
|
| Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. | 2003-06-16 |
|
| Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. | 2003-06-02 |
|
| Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors. | 2003-06-01 |
|
| Discovery of 3-amino-4-chlorophenyl P1 as a novel and potent benzamidine mimic via solid-phase synthesis of an isoxazoline library. | 2003-05-19 |
|
| Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids. | 2003-05-08 |
|
| A role for BRCA1 in sporadic breast cancer. | 2003-04-22 |
|
| Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. | 2003-04-08 |
|
| Identification and partial characterization of two inducible gelatin-cleavage activities localized to the sea urchin extraembryonic matrix, the hyaline layer. | 2003-04-07 |
|
| Purification, properties and substrate specificity of a digestive trypsin from Periplaneta americana (Dictyoptera) adults. | 2003-04 |
|
| Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors. | 2003-03-24 |
|
| Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket. | 2003-02-27 |
|
| Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors. | 2003-02-10 |
|
| Nonbenzamidine tetrazole derivatives as factor Xa inhibitors. | 2003-02-10 |
|
| A novel influenza A virus activating enzyme from porcine lung: purification and characterization. | 2003-02 |
|
| Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity. | 2003-01-31 |
|
| Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas. | 2003-01-31 |
|
| Disruption of vitellogenin gene function in adult honeybees by intra-abdominal injection of double-stranded RNA. | 2003-01-20 |
|
| Purification and partial characterization of feline classical pancreatic lipase. | 2003-01 |
|
| Inhibitors of benzamidine type influence the virulence properties of Porphyromonas gingivalis strains. | 2003 |
|
| Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. | 2003 |
|
| The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells. | 2002-12-16 |
|
| Pattern recognition and massively distributed computing. | 2002-12 |
|
| Inhibition of arginine gingipains (RgpB and HRgpA) with benzamidine inhibitors: zinc increases inhibitory potency. | 2002-11-20 |
|
| Thrombin inhibition by novel benzamidine derivatives: a free-energy perturbation study. | 2002-11-07 |
|
| Identification, characterization, and cloning of an immunoglobulin degrading enzyme in the cat flea, Ctenocephalides felis. | 2002-11 |
|
| Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway. | 2002-10-21 |
|
| Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum. | 2002-10-07 |
|
| The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator. | 2002-10-02 |
|
| Development and validation of a capillary electrophoresis method for ximelagatran assay and related substance determination in drug substance and tablets. | 2002-01-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:11:03 GMT 2025
by
admin
on
Mon Mar 31 19:11:03 GMT 2025
|
| Record UNII |
KUE3ZY3J1F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID8045012
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
618-39-3
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
KUE3ZY3J1F
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
DB03127
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
210-546-3
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
41033
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
243704
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
BENZAMIDINE
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
2332
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY | |||
|
C032157
Created by
admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
Kb
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
BINDING
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |